首页> 外文OA文献 >Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)

【2h】

Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)

机译：在P2X3受体拮抗剂GeFapixant（咳嗽-1和咳嗽-2）的两相3试验中，咳嗽患者患有难治性或无法解释的慢性咳嗽的患者中的患者触发和症状

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alyn Morice; Surinder Birring; Peter Dicpinigaitis; Lorcan McGarvey; Ian Pavord; Jaclyn Smith; Carmen La Rosa; Qing Li; Allison Martin Nguyen; Jonathan Schelfhout; Anjela Tzontcheva; David Muccino;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough [J] . Muccino David, Green Stuart Pulmonary pharmacology & therapeutics . 2019,第期

机译：关于GeFapixant的临床开发，P2X3受体拮抗剂治疗难治性慢性咳嗽的临床开发
2. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study [J] . Abdulqawi Rayid, Dockry Rachel, Holt Kimberley, The Lancet . 2015,第9974期

机译：难治性慢性咳嗽中的P2X3受体拮抗剂（AF-219）：一项随机，双盲，安慰剂对照的2期研究
3. Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework [J] . Elena Kum, Paul M. OByrne, Imran Satia, European respiratory review . 2021,第161期

机译：咳嗽症状严重程度耐火或无法解释的慢性咳嗽：系统的调查和概念框架
4. Clinical Epidemiological Study about Asian dust(kosa) effect on chronic cough patients [C] . Tomomi Higashi, Hiroyuki Nakamura, Masaki Fujimura Asian Aerosol Conference . 2015

机译：关于慢性咳嗽患者亚洲粉尘（KOSA）对慢性咳嗽患者影响的临床流行病学研究
5. Detecting Symptoms of Chronic Obstructive Pulmonary Disease and Congestive Heart Failure via Cough and Wheezing Sounds Using Smart-Phones and Machine Learning [D] . Windmon, Anthony. 2020

机译：通过咳嗽和机器学习检测慢性阻塞性肺病和充血性心力衰竭的症状
6. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant a P2X3 receptor antagonist in refractory or unexplained chronic cough [O] . David R. Muccino, Alyn H. Morice, Surinder S. Birring, 2020

机译：GeFapixantP2x3受体拮抗剂的两相3种随机对照试验（咳嗽-1和咳嗽-2）的设计和理论在难治性或无法解释的慢性咳嗽中
7. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough [O] . David R. Muccino, Alyn H. Morice, Surinder S. Birring, 2020

机译：GeFapixant，P2x3受体拮抗剂的两相3种随机对照试验（咳嗽-1和咳嗽-2）的设计和理论，在难治性或无法解释的慢性咳嗽中

Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)

著录项

引文网络

相似文献

相关主题

期刊订阅